General MedicationsINJECTIONGeneric
VIRA-A
VIDARABINE
Standard Dose
EQ 187.4MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary
Approval overview VIRA-A is listed in Drugs@FDA under application 050523 (NDA).
Review priority: PRIORITY Marketing status: Discontinued Active ingredient VIDARABINE Form and strength INJECTABLE;INJECTION - EQ 187.4MG BASE/ML Sponsor PARKEDALE Submission history Latest submission status date: 1978-10-18 00:00:00.
Structured Monograph
Clinical summary
Approval overview VIRA-A is listed in Drugs@FDA under application 050523 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient VIDARABINE Form and strength INJECTABLE;INJECTION - EQ 187.4MG BASE/ML Sponsor PARKEDALE Submission history Latest submission status date: 1978-10-18 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.